Welcure Drugs & Pharmaceuticals Ltd Cash Flow Annual
BSE: 524661 | NSE: - | ISIN: INE331C01025 | Sector: Biotechnology & Drugs| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Net Changein Cash | 0.45 | 0.11 | 0.02 | -0.06 |
| Net Income/ Starting Line | -5.49 | 2.78 | -0.17 | 0.10 |
| Changesin Working Capital | 7.21 | -224.82 | 0.01 | 0.01 |
| Cashfrom Operating Activities | 1.74 | -222.03 | -0.13 | 0.11 |
| Cashfrom Financing Activities | 0.00 | 222.20 | -0.02 | -1.49 |
| Depreciation/ Depletion | 0.02 | 0.01 | 0.04 | - |
| Other Investing Cash Flow Items Total | 0.00 | -0.05 | 0.16 | 1.32 |
| Capital Expenditures | -1.29 | -0.02 | - | - |
| period Type | - | - | - | - |
| Financing Cash Flow Items | 0.00 | - | -0.02 | -1.49 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -1.29 | -0.06 | 0.16 | 1.32 |
| Issuance( Retirement)of Debt Net | - | 123.20 | - | - |
| Issuance( Retirement)of Stock Net | - | 99.00 | - | - |
| Cash Taxes Paid | - | - | 0.00 | - |
Welcure Drugs & Pharmaceuticals Ltd Quick Links
Welcure Drugs & Pharmaceuticals Ltd Dividend Welcure Drugs & Pharmaceuticals Ltd Bonus Welcure Drugs & Pharmaceuticals Ltd News Welcure Drugs & Pharmaceuticals Ltd AGM Welcure Drugs & Pharmaceuticals Ltd Rights Welcure Drugs & Pharmaceuticals Ltd Splits Welcure Drugs & Pharmaceuticals Ltd Board Meetings Welcure Drugs & Pharmaceuticals Ltd Key Metrics Welcure Drugs & Pharmaceuticals Ltd Shareholdings Welcure Drugs & Pharmaceuticals Ltd Profit Loss Welcure Drugs & Pharmaceuticals Ltd Balance Sheet Welcure Drugs & Pharmaceuticals Ltd Q1 Results Welcure Drugs & Pharmaceuticals Ltd Q2 Results Welcure Drugs & Pharmaceuticals Ltd Q3 Results Welcure Drugs & Pharmaceuticals Ltd Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.